Atlas Trials

Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis

Clinical trial NCT02966834 · COMPLETED

Trial details

NCT number
NCT02966834
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cholestasis
Start date
2017-01-11
Primary completion
2020-04-15
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.